Top Clinical Trials companies in Hong Kong by Return on Equity (ROE)
Hong Kong
# |
Name |
Return on Equity (ROE) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
13.80%
|
Dec. 31, 2023 | USD 2.63 | -1.97% |
|
Hong Kong |
|
| 2 |
3.16%
|
Dec. 31, 2023 | USD 0.21 | -2.41% |
|
Hong Kong |
|
| 3 |
0.82%
|
Dec. 31, 2023 | USD 0.16 | 4.01% |
|
Hong Kong |
|
| 4 |
-30.40%
|
Dec. 31, 2023 | USD 5.25 | -2.96% |
|
Hong Kong |
|
| 5 |
-195.77%
|
Dec. 31, 2023 | USD 0.36 | -3.86% |
|
Hong Kong |
Frequently Asked Questions
-
Which Clinical Trials company in Hong Kong has the highest Return on Equity (ROE) ?
The Clinical Trials company in Hong Kong with the highest Return on Equity (ROE) is HUTCHMED (China) Limited (HKSE: 0013.HK) at 13.80%.
-
Which Clinical Trials company in Hong Kong has the lowest Return on Equity (ROE) ?
The Clinical Trials company in Hong Kong with the lowest Return on Equity (ROE) is Sirnaomics Ltd. (HKSE: 2257.HK) at -195.77%.
-
What are the top 10 Clinical Trials companies in Hong Kong by Return on Equity (ROE) ?
The top 10 Clinical Trials companies in Hong Kong by Return on Equity (ROE) are HUTCHMED (China) Limited, Frontage Holdings Corporation, Lee's Pharmaceutical Holdings Limited, Prenetics Global Limited and Sirnaomics Ltd..
-
What are the bottom 10 Clinical Trials companies in Hong Kong by Return on Equity (ROE) ?
The bottom 10 Clinical Trials companies in Hong Kong by Return on Equity (ROE) are Sirnaomics Ltd., Prenetics Global Limited, Lee's Pharmaceutical Holdings Limited, Frontage Holdings Corporation and HUTCHMED (China) Limited.
